Search Results - "Lasch, S. J."
-
1
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
Published in Science (American Association for the Advancement of Science) (09-07-1993)“…Immunoconjugates (BR96-DOX) were prepared between chimeric monoclonal antibody BR96 and the anticancer drug doxorubicin. The monoclonal antibody binds an…”
Get full text
Journal Article -
2
(6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin
Published in Bioconjugate chemistry (01-11-1993)“…The (6-maleimidocaproyl)hydrazone of doxorubicin was synthesized and conjugated to several mAbs, including chimeric BR96, via a Michael addition reaction to…”
Get full text
Journal Article -
3
Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates
Published in Cancer research (Chicago, Ill.) (1997)“…The internalizing anti-Le(y) monoclonal antibody (MAb) BR64 was conjugated to the anticancer drug doxorubicin (DOX) using an acid-labile hydrazone bond to the…”
Get full text
Journal Article -
4
Synthesis and antitumor activity of the immunoconjugate BR96-Dox
Published in Journal of controlled release (01-05-1996)“…BR96-Dox is an immunoconjugate (IC) in which doxorubicin (8 equivalents) is linked via an acid-labile hydrazone to the chimeric MAb BR96. It binds to a…”
Get full text
Journal Article Conference Proceeding -
5
Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Linkers: A Novel Method for Increasing the Potency of Doxorubicin Immunoconjugates
Published in Bioconjugate chemistry (01-03-1999)“…Immunoconjugates of monoclonal antibody BR96 and Doxorubicin have been prepared using a novel series of branched hydrazone linkers. Since each linker bound to…”
Get full text
Journal Article -
6
Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models
Published in Cancer research (Chicago, Ill.) (15-10-1992)“…The anticarcinoma antibody BR64 was conjugated to a doxorubicin derivative, doxorubicin 13-[3-(2-pyridyldithio)propionyl]hydrazone, and the resulting…”
Get full text
Journal Article -
7
Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity
Published in Bioconjugate chemistry (01-07-2002)“…The anticancer drug doxorubicin (DOX) has been linked to chimeric BR96, an internalizing monoclonal antibody that binds to a Lewisy-related, tumor-associated…”
Get full text
Journal Article -
8
Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers: Inhibition of Aggregation by Methoxytriethyleneglycol Chains
Published in Journal of medicinal chemistry (12-09-2002)“…High mole ratio BR96 immunoconjugates were synthesized using branched peptide−doxorubicin linkers designed to liberate doxorubicin following antigen-specific…”
Get full text
Journal Article -
9
Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages
Published in Bioorganic & medicinal chemistry letters (03-06-2002)“…Bivalent doxorubicin (DOX)-dipeptides ( 16a– c) were prepared and conjugated to the monoclonal antibody BR96. The dipeptides are cleaved by lysosomal proteases…”
Get full text
Journal Article -
10
BR96 conjugates of highly potent anthracyclines
Published in Bioorganic & medicinal chemistry letters (07-07-2003)“…The 6-maleimidocaproylhydrazone derivatives of highly potent antitumor agents 5-Diacetoxypentyldoxorubicin and Morpholinodoxorubicin were synthesized and…”
Get full text
Journal Article